Post-Roe Drug Delays Weigh on Patients, Providers

July 26, 2022

(Axios) – The post-Roe battlefield is spreading to pharmacies, where drugs that can cause fetal abnormalities or that have multiple uses that include ending pregnancies are being put through more scrutiny. The big picture: Some patients with rheumatoid arthritis, lupus and stomach ulcers are facing delays getting critical treatments while providers verify the drugs’ intended use to pharmacists and insurers. (Read More)